Latanoprost/Timolol Viatris

Timolol maleate, the active ingredient in Latanoprost/Timolol Viatris, is a beta blocker presented as an ophthalmic solution for ocular use. It reduces intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension. Combined with Latanoprost, a prostaglandin analog, the formulation targets both aqueous humor production and outflow to achieve better pressure control.

GNH USA supplies Latanoprost/Timolol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Latanoprost/Timolol is indicated for conditions affecting intra‑ocular pressure within the glaucoma disease family.

- Open-angle glaucoma: lowers intra‑ocular pressure to prevent optic nerve damage - Ocular hypertension: reduces elevated eye pressure to lower risk of glaucoma development - Secondary open-angle glaucoma: helps control pressure when caused by other ocular conditions

Common Side Effects: - Eye irritation or burning sensation - Blurred vision shortly after instillation - Redness of the conjunctiva - Itching or mild allergic reaction on the eyelid - Dry eye or foreign‑body sensation - Increased pigmentation of the iris

Serious or Rare Side Effects: - Severe allergic reaction with swelling of the eyelid or face - Unexpected rise in intra‑ocular pressure (rebound effect) - Systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm - Chest pain or signs of heart failure - Acute angle‑closure glaucoma - Vision loss

Before initiating therapy, evaluate patient-specific risk factors and monitor for adverse events.

- Assess cardiovascular status: avoid in patients with severe bradycardia, heart block, or decompensated heart failure - Monitor respiratory function: caution in asthma or chronic obstructive pulmonary disease - Check for sulfonamide or prostaglandin allergy: discontinue if hypersensitivity occurs - Avoid abrupt discontinuation: may cause rebound intra‑ocular pressure elevation - Pregnancy and lactation: use only if potential benefit justifies potential risk to the fetus or infant - Store at room temperature: keep in original container, protect from light and moisture

Latanoprost/Timolol may interact with other systemic or ocular agents; review concomitant medications.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): additive bradycardia or hypotension - Other ocular hypotensive agents (e.g., carbonic anhydrase inhibitors): excessive IOP lowering - Sympathomimetic eye drops (e.g., epinephrine): antagonistic effect reducing efficacy

Moderate Interactions (Monitor Closely):\n- Calcium channel blockers: may influence ocular blood flow and IOP response - Anticholinergic ophthalmic drops: possible alteration of pupil dynamics - Systemic antihypertensives: monitor blood pressure for additive lowering